Vikram G Shakkottai Selected Research

Chlorzoxazone

1/2021	A Chlorzoxazone-Baclofen Combination Improves Cerebellar Impairment in Spinocerebellar Ataxia Type 1.
1/2018	Targeting potassium channels to treat cerebellar ataxia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vikram G Shakkottai Research Topics

Disease

17	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2022 - 01/2009
13	Ataxia (Dyssynergia) 01/2022 - 10/2009
7	Cerebellar Ataxia (Dysmetria) 01/2022 - 02/2004
5	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 02/2021 - 09/2011
5	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2019 - 10/2014
3	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 11/2019 - 01/2016
2	Cerebellar Diseases (Cerebellar Syndrome) 01/2021 - 09/2011
1	Neurodevelopmental Disorders 01/2022
1	Channelopathies 01/2022
1	Demyelinating Diseases (Demyelinating Disease) 10/2020
1	Cognitive Dysfunction 02/2020
1	Vanishing White Matter Leukodystrophy with Ovarian Failure 02/2020
1	Leukoencephalopathies 02/2020
1	Body Weight (Weight, Body) 11/2019
1	Niemann-Pick Diseases (Niemann Pick Disease) 11/2019
1	Dystonia (Limb Dystonia) 12/2017
1	Tremor (Tremors) 01/2017
1	Brain Diseases (Brain Disorder) 05/2016
1	Movement Disorders (Movement Disorder) 05/2016
1	Atrophy 08/2015
1	Disease Progression 02/2015
1	Clinical Deterioration 02/2015
1	Huntington Disease (Huntington's Disease) 02/2015

Drug/Important Bio-Agent (IBA)

8	polyglutamineIBA 01/2020 - 09/2011
5	Potassium Channels (Potassium Channel)IBA 02/2021 - 08/2015
4	Ion Channels (Ion Channel)IBA 01/2022 - 10/2009
3	CalciumIBA 01/2022 - 01/2018
3	Glutamine (L-Glutamine)FDA Link 02/2021 - 10/2014
2	Pharmaceutical PreparationsIBA 01/2022 - 02/2015
2	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2022 - 08/2015
2	Antisense OligonucleotidesIBA 02/2021 - 01/2019
2	Baclofen FDA LinkGeneric 01/2021 - 01/2018
2	Chlorzoxazone FDA LinkGeneric 01/2021 - 01/2018
2	coenzyme Q10 (CoQ10)IBA 06/2019 - 02/2015
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2018
2	tributyl phosphate (TBP)IBA 12/2017 - 01/2017
1	Calcibiotic Root Canal SealerIBA 01/2022
1	NS 1619IBA 01/2022
1	PotassiumIBA 01/2022
1	Ataxin-3IBA 02/2021
1	Central Muscle RelaxantsIBA 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2020
1	Choline (Choline Chloride)IBA 10/2020
1	Inositol (Myoinositol)IBA 10/2020
1	N-acetylaspartate (N-acetyl aspartate)IBA 10/2020
1	Alanine-tRNA LigaseIBA 02/2020
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2020
1	Sirtuin 1IBA 01/2020
1	BilirubinIBA 11/2019
1	CholesterolIBA 11/2019
1	HDL LipoproteinsIBA 11/2019
1	src-Family KinasesIBA 12/2018
1	Glycoproteins (Glycoprotein)IBA 10/2018
1	LipidsIBA 10/2018
1	Protein Kinase CIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	protein kinase C gamma (PRKCG)IBA 01/2018
1	OligonucleotidesIBA 01/2018
1	IsoenzymesIBA 01/2018
1	EnzymesIBA 01/2018
1	Sodium Channels (Sodium Channel)IBA 05/2016
1	Amino Acids FDA Link 05/2016
1	HSP27 Heat-Shock ProteinsIBA 01/2016
1	Flufenamic AcidIBA 08/2015
1	Vitamin E FDA LinkGeneric 02/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2015
1	DNA (Deoxyribonucleic Acid)IBA 11/2013
1	fibroblast growth factor 14IBA 01/2009
1	Riluzole FDA LinkGeneric 02/2004
1	Neuroprotective AgentsIBA 02/2004

Therapy/Procedure

7	Therapeutics 02/2021 - 10/2009
1	Precision Medicine 01/2016
1	RNAi Therapeutics 10/2013